Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anhedonia, Development, and Emotions: Phenotyping and Therapeutics (ADEPT) Study

NCT05487885 is registered in ClinicalTrials.gov with Erika Forbes as lead sponsor.

NCT NCT05487885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics (ADEPT) Study
Lead sponsor
Erika Forbes
Phase
Phase 4
Overall status
Completed
Start date
July 22, 2022
Completion date
June 1, 2025
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, depression